Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CHU de Charleroi is a major Belgian academic hospital network and a leading healthcare provider in the Wallonia region. Affiliated with the Université Libre de Bruxelles (ULB), the institution operates as a teaching hospital, integrating high-level clinical care with medical education and extensive clinical research. The network includes several specialized sites, most notably the Hôpital Civil Marie Curie and the Hôpital André Vésale, offering expertise in oncology, cardiology, and psychiatry. Recently, CHU de Charleroi merged with Grand Hôpital de Charleroi (GHdC) to form the HUmani network, creating one of the largest hospital groups in Belgium to optimize patient care and medical infrastructure. The center is a frequent site for international clinical trials across various therapeutic modalities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centre Hospitalier Universitaire de Charleroi.